135 related articles for article (PubMed ID: 14612906)
1. MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status.
Müller HM; Fiegl H; Goebel G; Hubalek MM; Widschwendter A; Müller-Holzner E; Marth C; Widschwendter M
Br J Cancer; 2003 Nov; 89(10):1934-9. PubMed ID: 14612906
[TBL] [Abstract][Full Text] [Related]
2. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland.
Billard LM; Magdinier F; Lenoir GM; Frappart L; Dante R
Oncogene; 2002 Apr; 21(17):2704-12. PubMed ID: 11965543
[TBL] [Abstract][Full Text] [Related]
3. Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer.
Müller-Tidow C; Kügler K; Diederichs S; Klümpen S; Möller M; Vogt U; Metzger R; Schneider PM; Berdel WE; Serve H
Br J Cancer; 2001 Oct; 85(8):1168-74. PubMed ID: 11710831
[TBL] [Abstract][Full Text] [Related]
4. Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver.
Esfandiari F; Green R; Cotterman RF; Pogribny IP; James SJ; Miller JW
Carcinogenesis; 2003 Dec; 24(12):1935-40. PubMed ID: 12949043
[TBL] [Abstract][Full Text] [Related]
5. Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2.
Patra SK; Patra A; Zhao H; Carroll P; Dahiya R
Biochem Biophys Res Commun; 2003 Mar; 302(4):759-66. PubMed ID: 12646234
[TBL] [Abstract][Full Text] [Related]
6. Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer.
Fang JY; Cheng ZH; Chen YX; Lu R; Yang L; Zhu HY; Lu LG
World J Gastroenterol; 2004 Dec; 10(23):3394-8. PubMed ID: 15526354
[TBL] [Abstract][Full Text] [Related]
7. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
Lin X; Nelson WG
Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
[TBL] [Abstract][Full Text] [Related]
8. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis.
Saito Y; Kanai Y; Sakamoto M; Saito H; Ishii H; Hirohashi S
Hepatology; 2001 Mar; 33(3):561-8. PubMed ID: 11230735
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.
Bièche I; Girault I; Sabourin JC; Tozlu S; Driouch K; Vidaud M; Lidereau R
Br J Cancer; 2003 Mar; 88(6):863-70. PubMed ID: 12644823
[TBL] [Abstract][Full Text] [Related]
10. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
11. Upregulated exosomal miR-221/222 promotes cervical cancer via repressing methyl-CpG-binding domain protein 2.
Pan ZX; Zhang XY; Chen SR; Li CZ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3645-3653. PubMed ID: 31114989
[TBL] [Abstract][Full Text] [Related]
12. The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells.
Jung BP; Jugloff DG; Zhang G; Logan R; Brown S; Eubanks JH
J Neurobiol; 2003 Apr; 55(1):86-96. PubMed ID: 12605461
[TBL] [Abstract][Full Text] [Related]
13. Association of chemotactic factor receptor 5 gene with breast cancer.
Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
[TBL] [Abstract][Full Text] [Related]
14. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of the methyl-cytosine binding protein 2 gene in embryonic and adult brain of zebrafish.
Coverdale LE; Martyniuk CJ; Trudeau VL; Martin CC
Brain Res Dev Brain Res; 2004 Nov; 153(2):281-7. PubMed ID: 15527897
[TBL] [Abstract][Full Text] [Related]
16. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
17. HDAC6 expression is correlated with better survival in breast cancer.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Omoto Y; Ando Y; Mita K; Hamaguchi M; Hayashi S; Iwase H
Clin Cancer Res; 2004 Oct; 10(20):6962-8. PubMed ID: 15501975
[TBL] [Abstract][Full Text] [Related]
18. DNA binding of methyl-CpG-binding protein MeCP2 in human MCF7 cells.
Koch C; Strätling WH
Biochemistry; 2004 May; 43(17):5011-21. PubMed ID: 15109260
[TBL] [Abstract][Full Text] [Related]
19. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
[TBL] [Abstract][Full Text] [Related]
20. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]